Catherine (Fanego) Merrill, Pharm.D.
About Catherine (Fanego) Merrill, Pharm.D.
Catherine (Fanego) Merrill, Pharm.D., is the Director of Immuno-Oncology Medical Communications at Bristol-Myers Squibb, with extensive experience in medical strategic planning and scientific communications within the field of Immuno-Oncology.
Current Position at Bristol-Myers Squibb
Catherine (Fanego) Merrill, Pharm.D., currently holds the position of Director, Immuno-Oncology Medical Communications at Bristol-Myers Squibb. In this role, she oversees the development and distribution of medical information related to immuno-oncology, ensuring the accuracy and effectiveness of communications within the company and externally.
Previous Roles at Bristol-Myers Squibb
Catherine has held multiple roles at Bristol-Myers Squibb over the years, including Associate Director, Immuno-Oncology Global Medical Publications from 2016 to 2019, where she was responsible for managing global publication strategies. Prior to that, she served as Manager, Immuno-Oncology Medical Launch Scientist from 2015 to 2016, focusing on strategies for new medical launches. From 2013 to 2015, she was Manager, Immuno-Oncology US Medical Strategy. Earlier in her career, from 2011 to 2013, she worked as a Global/US Medical Oncology Fellow in collaboration with Rutgers University.
Educational Background
Catherine earned her Doctor of Pharmacy (Pharm.D.) degree from the Ernest Mario School of Pharmacy at Rutgers, the State University of New Jersey. Her academic journey spanned from 2005 to 2011. During her time at Rutgers, she developed a strong foundation in pharmacy and pharmaceutical sciences.
Experience at Rutgers University
From 2011 to 2013, Catherine served as an Adjunct Faculty member at Rutgers University in Piscataway, NJ. In this role, she contributed to the academic development of students while simultaneously gaining practical experience through her fellowship at Bristol-Myers Squibb.
Early Career Experiences
In her early career, Catherine gained diverse experiences including a one-month clerkship at ICC Lowe in 2010, and a two-month stint at Eisai working in drug information in 2008. These roles provided her with valuable insights and foundational knowledge that have contributed to her extensive expertise in medical communications and strategic planning.
Skills and Expertise
Catherine possesses extensive experience in medical strategic planning and scientific communications within the field of immuno-oncology. She has strong project management and relationship management skills, enabling her to collaborate effectively in cross-functional teams. Her background in publication planning and thought leader interactions further enhances her capabilities in medical communications.